Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Depression | 12 | 2024 | 518 | 2.240 |
Why?
|
Suicide | 10 | 2024 | 126 | 2.160 |
Why?
|
Autism Spectrum Disorder | 8 | 2024 | 164 | 1.620 |
Why?
|
Health Care Costs | 9 | 2022 | 251 | 1.610 |
Why?
|
Depressive Disorder, Major | 7 | 2022 | 127 | 1.490 |
Why?
|
Depressive Disorder | 14 | 2019 | 231 | 1.490 |
Why?
|
Adolescent | 49 | 2024 | 3798 | 1.370 |
Why?
|
Humans | 95 | 2024 | 18430 | 1.310 |
Why?
|
Behavior Therapy | 6 | 2023 | 155 | 1.270 |
Why?
|
Mental Health Services | 12 | 2019 | 161 | 1.250 |
Why?
|
Female | 74 | 2024 | 13136 | 1.210 |
Why?
|
Cost-Benefit Analysis | 8 | 2021 | 270 | 1.180 |
Why?
|
Male | 65 | 2024 | 10440 | 1.160 |
Why?
|
Quality of Life | 5 | 2023 | 529 | 1.130 |
Why?
|
Depressive Disorder, Treatment-Resistant | 3 | 2022 | 14 | 1.130 |
Why?
|
Patient Acceptance of Health Care | 7 | 2022 | 407 | 1.100 |
Why?
|
Primary Health Care | 9 | 2022 | 848 | 1.100 |
Why?
|
Anxiety | 5 | 2023 | 156 | 1.030 |
Why?
|
Mental Disorders | 10 | 2022 | 295 | 1.010 |
Why?
|
Health Maintenance Organizations | 17 | 2012 | 479 | 1.000 |
Why?
|
Anxiety Disorders | 8 | 2023 | 93 | 0.900 |
Why?
|
Serotonin Uptake Inhibitors | 5 | 2013 | 74 | 0.830 |
Why?
|
Suicide, Attempted | 4 | 2022 | 98 | 0.830 |
Why?
|
Child | 25 | 2024 | 2571 | 0.820 |
Why?
|
Patient Acuity | 1 | 2022 | 7 | 0.810 |
Why?
|
Delivery of Health Care, Integrated | 5 | 2023 | 567 | 0.790 |
Why?
|
Cost of Illness | 3 | 2014 | 100 | 0.780 |
Why?
|
Opioid-Related Disorders | 3 | 2014 | 168 | 0.780 |
Why?
|
United States | 31 | 2024 | 4164 | 0.770 |
Why?
|
Combined Modality Therapy | 6 | 2014 | 150 | 0.760 |
Why?
|
Substance-Related Disorders | 7 | 2020 | 439 | 0.740 |
Why?
|
Psychotic Disorders | 4 | 2024 | 47 | 0.680 |
Why?
|
Patient Health Questionnaire | 3 | 2024 | 18 | 0.660 |
Why?
|
Adult | 39 | 2024 | 7910 | 0.660 |
Why?
|
Genetic Carrier Screening | 5 | 2018 | 22 | 0.620 |
Why?
|
Psychotropic Drugs | 8 | 2017 | 37 | 0.590 |
Why?
|
Delivery of Health Care | 5 | 2018 | 444 | 0.580 |
Why?
|
Buprenorphine | 2 | 2014 | 48 | 0.570 |
Why?
|
Psychology, Adolescent | 1 | 2016 | 15 | 0.570 |
Why?
|
Patient Selection | 4 | 2020 | 198 | 0.570 |
Why?
|
Self Care | 5 | 2011 | 175 | 0.560 |
Why?
|
Middle Aged | 28 | 2024 | 8284 | 0.560 |
Why?
|
Binge-Eating Disorder | 3 | 2010 | 13 | 0.540 |
Why?
|
Medicaid | 7 | 2013 | 211 | 0.500 |
Why?
|
Child, Preschool | 14 | 2024 | 1478 | 0.470 |
Why?
|
Health Policy | 2 | 2014 | 136 | 0.470 |
Why?
|
Antidepressive Agents | 6 | 2018 | 162 | 0.470 |
Why?
|
Genetic Testing | 7 | 2023 | 89 | 0.470 |
Why?
|
Motivation | 3 | 2023 | 137 | 0.470 |
Why?
|
Adolescent Behavior | 2 | 2013 | 129 | 0.470 |
Why?
|
Commerce | 1 | 2014 | 49 | 0.470 |
Why?
|
Child of Impaired Parents | 6 | 2016 | 33 | 0.460 |
Why?
|
Treatment Outcome | 14 | 2022 | 1296 | 0.450 |
Why?
|
Outcome Assessment (Health Care) | 2 | 2014 | 254 | 0.450 |
Why?
|
Bulimia Nervosa | 3 | 2010 | 10 | 0.450 |
Why?
|
Surveys and Questionnaires | 9 | 2022 | 1389 | 0.440 |
Why?
|
Cyclohexanols | 4 | 2013 | 36 | 0.440 |
Why?
|
Genetic Diseases, Inborn | 3 | 2018 | 12 | 0.430 |
Why?
|
Retrospective Studies | 11 | 2024 | 2550 | 0.420 |
Why?
|
Parents | 6 | 2017 | 309 | 0.410 |
Why?
|
Case-Control Studies | 9 | 2022 | 1173 | 0.410 |
Why?
|
Bipolar Disorder | 3 | 2020 | 63 | 0.400 |
Why?
|
Manuals as Topic | 2 | 2010 | 7 | 0.390 |
Why?
|
Follow-Up Studies | 12 | 2019 | 1269 | 0.380 |
Why?
|
Antipsychotic Agents | 3 | 2024 | 57 | 0.370 |
Why?
|
Methadone | 1 | 2010 | 11 | 0.370 |
Why?
|
Prepaid Health Plans | 1 | 2010 | 22 | 0.370 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2019 | 342 | 0.360 |
Why?
|
Opiate Substitution Treatment | 1 | 2010 | 45 | 0.360 |
Why?
|
Child Health | 2 | 2023 | 34 | 0.360 |
Why?
|
Schizophrenia | 3 | 2024 | 79 | 0.360 |
Why?
|
Health Care Surveys | 2 | 2017 | 247 | 0.350 |
Why?
|
Life Style | 1 | 2012 | 342 | 0.350 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 5 | 2019 | 70 | 0.350 |
Why?
|
State Health Plans | 2 | 2000 | 44 | 0.350 |
Why?
|
Overweight | 1 | 2012 | 276 | 0.340 |
Why?
|
Weight Loss | 1 | 2012 | 321 | 0.330 |
Why?
|
Preconception Care | 4 | 2018 | 48 | 0.330 |
Why?
|
Preventive Health Services | 3 | 2016 | 166 | 0.310 |
Why?
|
Psychiatric Status Rating Scales | 9 | 2017 | 129 | 0.300 |
Why?
|
Risk Factors | 9 | 2022 | 3449 | 0.290 |
Why?
|
Self-Injurious Behavior | 2 | 2024 | 44 | 0.280 |
Why?
|
Electronic Health Records | 7 | 2023 | 747 | 0.280 |
Why?
|
Age Factors | 4 | 2020 | 965 | 0.270 |
Why?
|
Family Planning Services | 2 | 2016 | 27 | 0.270 |
Why?
|
Genome, Human | 2 | 2016 | 42 | 0.270 |
Why?
|
Young Adult | 10 | 2024 | 2518 | 0.260 |
Why?
|
Mammography | 2 | 2023 | 174 | 0.260 |
Why?
|
Mental Health | 3 | 2023 | 168 | 0.250 |
Why?
|
Health Status | 3 | 2020 | 328 | 0.250 |
Why?
|
Ethnic Groups | 4 | 2019 | 501 | 0.250 |
Why?
|
Patient Compliance | 4 | 2019 | 318 | 0.250 |
Why?
|
Health Expenditures | 3 | 2018 | 82 | 0.240 |
Why?
|
Practice Patterns, Physicians' | 4 | 2013 | 350 | 0.240 |
Why?
|
Breast Neoplasms | 2 | 2023 | 1037 | 0.240 |
Why?
|
Rural Population | 1 | 2024 | 52 | 0.240 |
Why?
|
Clozapine | 1 | 2024 | 5 | 0.240 |
Why?
|
Vaginal Smears | 1 | 2004 | 50 | 0.230 |
Why?
|
Community-Institutional Relations | 1 | 2004 | 47 | 0.230 |
Why?
|
Genetic Counseling | 4 | 2016 | 35 | 0.230 |
Why?
|
Patient Care | 1 | 2023 | 36 | 0.230 |
Why?
|
Health Services | 3 | 2015 | 117 | 0.230 |
Why?
|
Aged | 9 | 2022 | 6417 | 0.220 |
Why?
|
Chronic Pain | 1 | 2024 | 128 | 0.210 |
Why?
|
Drug Utilization | 5 | 2003 | 134 | 0.210 |
Why?
|
Utilization Review | 3 | 2018 | 56 | 0.210 |
Why?
|
Minority Groups | 1 | 2023 | 105 | 0.210 |
Why?
|
Sequence Analysis, DNA | 3 | 2016 | 38 | 0.210 |
Why?
|
Child Abuse | 1 | 2023 | 43 | 0.210 |
Why?
|
Natural Language Processing | 1 | 2023 | 57 | 0.200 |
Why?
|
Alcohol Drinking | 2 | 2004 | 375 | 0.200 |
Why?
|
Cohort Studies | 2 | 2022 | 2672 | 0.200 |
Why?
|
Venlafaxine Hydrochloride | 4 | 2013 | 37 | 0.200 |
Why?
|
Longitudinal Studies | 4 | 2017 | 724 | 0.200 |
Why?
|
Antidepressive Agents, Second-Generation | 2 | 2012 | 28 | 0.190 |
Why?
|
Risk Assessment | 3 | 2024 | 1143 | 0.190 |
Why?
|
Infant | 7 | 2024 | 1245 | 0.190 |
Why?
|
Community Mental Health Services | 2 | 2002 | 33 | 0.190 |
Why?
|
Telemedicine | 1 | 2024 | 184 | 0.190 |
Why?
|
Prevalence | 5 | 2024 | 911 | 0.190 |
Why?
|
Oregon | 7 | 2006 | 222 | 0.190 |
Why?
|
Sex Factors | 4 | 2020 | 661 | 0.190 |
Why?
|
Genomics | 2 | 2018 | 66 | 0.180 |
Why?
|
Genetic Research | 1 | 2020 | 8 | 0.180 |
Why?
|
Prospective Studies | 2 | 2023 | 1314 | 0.180 |
Why?
|
Social Change | 1 | 2000 | 1 | 0.180 |
Why?
|
Behavior Control | 1 | 2000 | 4 | 0.180 |
Why?
|
Child Behavior Disorders | 1 | 2000 | 18 | 0.180 |
Why?
|
Managed Care Programs | 4 | 2010 | 347 | 0.170 |
Why?
|
Models, Psychological | 1 | 2019 | 25 | 0.170 |
Why?
|
Benzodiazepines | 1 | 2019 | 26 | 0.170 |
Why?
|
Health Plan Implementation | 1 | 2000 | 41 | 0.170 |
Why?
|
Sleep Wake Disorders | 1 | 2019 | 38 | 0.170 |
Why?
|
Machine Learning | 1 | 2019 | 44 | 0.170 |
Why?
|
Patient Participation | 1 | 2020 | 144 | 0.160 |
Why?
|
Socioeconomic Factors | 2 | 2020 | 673 | 0.160 |
Why?
|
Psychotherapy, Brief | 2 | 2017 | 20 | 0.160 |
Why?
|
Guideline Adherence | 1 | 2019 | 162 | 0.160 |
Why?
|
Suicidal Ideation | 4 | 2024 | 100 | 0.160 |
Why?
|
Neonatal Screening | 1 | 2018 | 13 | 0.160 |
Why?
|
Quality of Health Care | 2 | 2004 | 347 | 0.150 |
Why?
|
Psychotherapy | 2 | 2016 | 59 | 0.150 |
Why?
|
Clinical Decision-Making | 1 | 2018 | 36 | 0.150 |
Why?
|
Quality-Adjusted Life Years | 3 | 2018 | 41 | 0.150 |
Why?
|
Patient Care Planning | 1 | 2018 | 51 | 0.150 |
Why?
|
Skin Diseases | 1 | 2017 | 10 | 0.150 |
Why?
|
Neoplasms | 1 | 2022 | 457 | 0.150 |
Why?
|
Decision Making | 5 | 2016 | 204 | 0.150 |
Why?
|
Public Health Administration | 1 | 1997 | 6 | 0.150 |
Why?
|
State Government | 1 | 1997 | 14 | 0.140 |
Why?
|
Health Care Rationing | 1 | 1997 | 14 | 0.140 |
Why?
|
Drug Therapy, Combination | 2 | 2011 | 119 | 0.140 |
Why?
|
Affective Disorders, Psychotic | 1 | 2017 | 10 | 0.140 |
Why?
|
Interview, Psychological | 1 | 2016 | 19 | 0.140 |
Why?
|
Developmental Disabilities | 1 | 2017 | 53 | 0.140 |
Why?
|
Truth Disclosure | 1 | 2016 | 17 | 0.130 |
Why?
|
Counseling | 2 | 2015 | 197 | 0.130 |
Why?
|
Body Mass Index | 2 | 2012 | 974 | 0.130 |
Why?
|
Preimplantation Diagnosis | 1 | 2015 | 3 | 0.130 |
Why?
|
Incidence | 3 | 2017 | 1314 | 0.130 |
Why?
|
Psychotherapy, Group | 3 | 2013 | 26 | 0.120 |
Why?
|
Insurance, Health | 1 | 2017 | 217 | 0.120 |
Why?
|
Comorbidity | 6 | 2014 | 619 | 0.120 |
Why?
|
Washington | 4 | 2023 | 388 | 0.120 |
Why?
|
Drug Resistance | 2 | 2012 | 30 | 0.120 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 1360 | 0.120 |
Why?
|
Models, Theoretical | 1 | 2014 | 76 | 0.120 |
Why?
|
Pneumonia | 1 | 2014 | 56 | 0.120 |
Why?
|
Diagnostic Errors | 1 | 2014 | 29 | 0.120 |
Why?
|
Off-Label Use | 1 | 2013 | 14 | 0.120 |
Why?
|
Anorexia Nervosa | 2 | 2010 | 5 | 0.110 |
Why?
|
Decision Support Techniques | 1 | 2014 | 95 | 0.110 |
Why?
|
Secondary Prevention | 2 | 2010 | 52 | 0.110 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 2 | 2013 | 10 | 0.110 |
Why?
|
Continental Population Groups | 1 | 2015 | 315 | 0.110 |
Why?
|
Drug Prescriptions | 1 | 2014 | 157 | 0.110 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 195 | 0.110 |
Why?
|
Substance Abuse Treatment Centers | 2 | 2004 | 75 | 0.110 |
Why?
|
Population Surveillance | 1 | 2014 | 271 | 0.110 |
Why?
|
Research Design | 1 | 2015 | 402 | 0.110 |
Why?
|
Patient Readmission | 1 | 2014 | 162 | 0.110 |
Why?
|
Myocardial Infarction | 1 | 2014 | 249 | 0.100 |
Why?
|
Program Development | 2 | 2011 | 81 | 0.100 |
Why?
|
Anhedonia | 1 | 2012 | 5 | 0.100 |
Why?
|
Internet | 2 | 2005 | 243 | 0.100 |
Why?
|
Risk | 3 | 2019 | 552 | 0.100 |
Why?
|
Severity of Illness Index | 5 | 2013 | 476 | 0.100 |
Why?
|
Parent-Child Relations | 1 | 2012 | 55 | 0.100 |
Why?
|
Bulimia | 1 | 2011 | 8 | 0.100 |
Why?
|
Referral and Consultation | 2 | 2017 | 180 | 0.090 |
Why?
|
Analgesics, Opioid | 1 | 2013 | 241 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 2 | 2023 | 414 | 0.090 |
Why?
|
Cost Savings | 1 | 2010 | 25 | 0.090 |
Why?
|
Diet | 1 | 2012 | 371 | 0.090 |
Why?
|
Sensitivity and Specificity | 2 | 2015 | 321 | 0.080 |
Why?
|
Health Behavior | 1 | 2012 | 374 | 0.080 |
Why?
|
Heart Failure | 1 | 2014 | 398 | 0.080 |
Why?
|
Self-Help Groups | 1 | 2009 | 32 | 0.080 |
Why?
|
Psychometrics | 3 | 2017 | 124 | 0.080 |
Why?
|
Time Factors | 4 | 2014 | 1136 | 0.080 |
Why?
|
Central Nervous System Stimulants | 2 | 2017 | 29 | 0.080 |
Why?
|
Focus Groups | 3 | 2016 | 154 | 0.080 |
Why?
|
Infant, Newborn | 2 | 2023 | 872 | 0.080 |
Why?
|
Feeding and Eating Disorders | 1 | 2007 | 17 | 0.080 |
Why?
|
Health Services Research | 3 | 2018 | 264 | 0.070 |
Why?
|
Exercise | 1 | 2012 | 495 | 0.070 |
Why?
|
Northwestern United States | 3 | 2017 | 58 | 0.070 |
Why?
|
Exome | 2 | 2016 | 25 | 0.070 |
Why?
|
Heterozygote | 2 | 2016 | 29 | 0.070 |
Why?
|
Terminology as Topic | 2 | 2016 | 21 | 0.070 |
Why?
|
Incidental Findings | 2 | 2016 | 30 | 0.070 |
Why?
|
Interviews as Topic | 3 | 2018 | 327 | 0.070 |
Why?
|
Qualitative Research | 2 | 2016 | 272 | 0.060 |
Why?
|
Logistic Models | 3 | 2019 | 962 | 0.060 |
Why?
|
Pain Management | 1 | 2024 | 59 | 0.060 |
Why?
|
Pragmatic Clinical Trials as Topic | 1 | 2024 | 56 | 0.060 |
Why?
|
Physical Fitness | 1 | 2004 | 76 | 0.060 |
Why?
|
Time and Motion Studies | 1 | 2023 | 3 | 0.060 |
Why?
|
Ambulatory Care | 2 | 2018 | 266 | 0.060 |
Why?
|
Behavioral Symptoms | 1 | 2013 | 4 | 0.060 |
Why?
|
Citalopram | 1 | 2013 | 14 | 0.060 |
Why?
|
Remission Induction | 1 | 2013 | 25 | 0.060 |
Why?
|
Fluoxetine | 1 | 2013 | 26 | 0.060 |
Why?
|
Paroxetine | 1 | 2013 | 23 | 0.050 |
Why?
|
Veterans | 1 | 2024 | 138 | 0.050 |
Why?
|
Drug Utilization Review | 1 | 2003 | 26 | 0.050 |
Why?
|
Gender Identity | 1 | 2002 | 36 | 0.050 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2003 | 35 | 0.050 |
Why?
|
Women's Health | 1 | 2004 | 207 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2004 | 226 | 0.050 |
Why?
|
International Classification of Diseases | 1 | 2023 | 87 | 0.050 |
Why?
|
Germ-Line Mutation | 1 | 2022 | 23 | 0.050 |
Why?
|
Adjustment Disorders | 1 | 2002 | 2 | 0.050 |
Why?
|
Mastectomy | 1 | 2022 | 39 | 0.050 |
Why?
|
Pregnancy | 2 | 2018 | 1516 | 0.050 |
Why?
|
California | 2 | 2017 | 2365 | 0.050 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 13 | 0.050 |
Why?
|
Methylphenidate | 1 | 2000 | 4 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2015 | 399 | 0.040 |
Why?
|
Models, Organizational | 1 | 2000 | 65 | 0.040 |
Why?
|
Oceanic Ancestry Group | 1 | 2019 | 33 | 0.040 |
Why?
|
Indians, North American | 1 | 2019 | 50 | 0.040 |
Why?
|
Mentoring | 1 | 2019 | 28 | 0.040 |
Why?
|
Religion and Medicine | 1 | 2018 | 3 | 0.040 |
Why?
|
Asian Americans | 1 | 2019 | 182 | 0.040 |
Why?
|
Hospitalization | 1 | 2024 | 847 | 0.040 |
Why?
|
Reproductive Health | 1 | 2018 | 12 | 0.040 |
Why?
|
Income | 1 | 2018 | 98 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2018 | 23 | 0.040 |
Why?
|
Personality Assessment | 2 | 2012 | 15 | 0.040 |
Why?
|
Early Detection of Cancer | 1 | 2023 | 526 | 0.040 |
Why?
|
Self Report | 1 | 2019 | 256 | 0.040 |
Why?
|
Patient Admission | 1 | 2018 | 76 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 333 | 0.040 |
Why?
|
Least-Squares Analysis | 1 | 1997 | 16 | 0.040 |
Why?
|
Ohio | 1 | 1997 | 23 | 0.040 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2017 | 4 | 0.040 |
Why?
|
Atomoxetine Hydrochloride | 1 | 2017 | 4 | 0.040 |
Why?
|
Hispanic Americans | 1 | 2019 | 428 | 0.040 |
Why?
|
Financing, Government | 1 | 1997 | 32 | 0.040 |
Why?
|
European Continental Ancestry Group | 1 | 2019 | 554 | 0.040 |
Why?
|
Taxes | 1 | 1997 | 19 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2000 | 320 | 0.040 |
Why?
|
Patient Reported Outcome Measures | 1 | 2016 | 54 | 0.030 |
Why?
|
African Americans | 1 | 2019 | 490 | 0.030 |
Why?
|
Colorado | 1 | 2017 | 211 | 0.030 |
Why?
|
Treatment Refusal | 1 | 2016 | 38 | 0.030 |
Why?
|
Emergency Medical Services | 1 | 2016 | 47 | 0.030 |
Why?
|
Causality | 1 | 2016 | 43 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2016 | 232 | 0.030 |
Why?
|
Family | 1 | 2016 | 120 | 0.030 |
Why?
|
Medical Records, Problem-Oriented | 1 | 2014 | 3 | 0.030 |
Why?
|
Insurance Claim Reporting | 1 | 2014 | 8 | 0.030 |
Why?
|
Attitude to Health | 1 | 2015 | 177 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 2013 | 35 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2013 | 47 | 0.030 |
Why?
|
Needs Assessment | 1 | 2014 | 69 | 0.030 |
Why?
|
Drug Substitution | 1 | 2012 | 10 | 0.030 |
Why?
|
Affect | 1 | 2012 | 26 | 0.030 |
Why?
|
Double-Blind Method | 1 | 2012 | 165 | 0.020 |
Why?
|
Adolescent Health Services | 1 | 2001 | 43 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2011 | 96 | 0.020 |
Why?
|
Psychopathology | 1 | 2010 | 4 | 0.020 |
Why?
|
Personality Inventory | 1 | 2010 | 14 | 0.020 |
Why?
|
Social Adjustment | 1 | 2010 | 16 | 0.020 |
Why?
|
Body Image | 1 | 2010 | 22 | 0.020 |
Why?
|
Child Health Services | 1 | 2001 | 129 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2010 | 168 | 0.020 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2007 | 59 | 0.020 |
Why?
|
Office Visits | 1 | 2007 | 86 | 0.020 |
Why?
|
Cost Control | 1 | 2006 | 25 | 0.020 |
Why?
|
Observer Variation | 1 | 2005 | 40 | 0.020 |
Why?
|
Cues | 1 | 2005 | 9 | 0.020 |
Why?
|
Recurrence | 1 | 2005 | 187 | 0.020 |
Why?
|
Telephone | 1 | 2005 | 179 | 0.010 |
Why?
|
Algorithms | 1 | 2005 | 241 | 0.010 |
Why?
|
Case Management | 1 | 2004 | 37 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2004 | 167 | 0.010 |
Why?
|
Weight Gain | 1 | 2005 | 181 | 0.010 |
Why?
|
Retention (Psychology) | 1 | 2002 | 7 | 0.010 |
Why?
|
Family Relations | 1 | 2003 | 18 | 0.010 |
Why?
|
Patient Dropouts | 1 | 2002 | 23 | 0.010 |
Why?
|
Sex Distribution | 1 | 2003 | 198 | 0.010 |
Why?
|
Medical Records Systems, Computerized | 1 | 2003 | 95 | 0.010 |
Why?
|
Age Distribution | 1 | 2003 | 261 | 0.010 |
Why?
|
Databases, Factual | 1 | 2002 | 327 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2002 | 214 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2004 | 2003 | 0.010 |
Why?
|